2021
DOI: 10.3389/fbioe.2021.747637
|View full text |Cite
|
Sign up to set email alerts
|

Self-Assembly Engineering Nanodrugs Composed of Paclitaxel and Curcumin for the Combined Treatment of Triple Negative Breast Cancer

Abstract: The clinical outcomes of triple-negative breast cancer (TNBC) chemotherapy are unsatisfactory. Water solubility and biosafety of chemo drugs are also major barriers for achieving satisfactory treatment effect. In this study, we have reported a combinational strategy by self-assembly engineering nanodrugs PC NDs, which were composed of paclitaxel (PTX) and curcumin (Cur), for effective and safe TNBC chemotherapy. PC NDs were prepared through reprecipitation method without using any additional carriers. The PC N… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 45 publications
3
9
0
Order By: Relevance
“…These data are in agreement with literature reports accounting for a limited efficacy of PTX on in vitro 4T1 cells [ 49 , 50 ] and on primary 4T1 tumor models [ 51 ].…”
Section: Resultssupporting
confidence: 93%
See 2 more Smart Citations
“…These data are in agreement with literature reports accounting for a limited efficacy of PTX on in vitro 4T1 cells [ 49 , 50 ] and on primary 4T1 tumor models [ 51 ].…”
Section: Resultssupporting
confidence: 93%
“…To exclude that the scarce cytotoxic response to nanoparticles was due to an inefficient prodrug's activation in 4T1 cells, we assessed the cytotoxicity of free PTX formulated in standard conditions (e.g., DMSO), showing very limited efficacy, and comparable to that exerted by our nanosystems (Figure S12). These data are in agreement with literature reports accounting for a limited efficacy of PTX on in vitro 4T1 cells [49,50] and on primary 4T1 tumor models [51].…”
Section: In Vitro Combination Therapy With Mal-ptx 2 S@pbasupporting
confidence: 93%
See 1 more Smart Citation
“…It is a natural substance derived from the needles and bark of the Pacific yew tree. It is a mitotic inhibitor used primarily in cancer chemotherapy, which can be used in the treatment of various cancers, including ovarian cancer, esophagus cancer, small and non–small-cell lung cancer, multiple myeloma cancer, bladder cancer, breast cancer, head and neck cancer, colon cancer, and Kaposi’s sarcoma ( Khalifa et al, 2019 ; Chen et al, 2021 ; Peng et al, 2021 ; Zuo et al, 2021 ). PTX is a microtubule stabilizing drug, which can prevent cytoskeletal microtubules from depolymerizing into free tubulin.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, carrier-free drug delivery systems, fabricated by self-assembly or co-assembly of pure drug molecules, have attracted substantial attention (Qin et al, 2017;Mei et al, 2022). Pure drug molecules without any chemical modification can spontaneously form uniform NPs by employing several methods Sun et al, 2019;Zuo et al, 2021). Compared with free drugs, carrier-free nanodrugs afford improved bioavailability, prolonged blood circulation times, and superior tumor accumulation (Zheng et al, 2021).…”
Section: Introductionmentioning
confidence: 99%